EHI
Eagle Health Investments Portfolio holdings
AUM
$405M
This Quarter Return
+16.18%
1 Year Return
+14.19%
3 Year Return
+134.25%
5 Year Return
–
10 Year Return
–
AUM
$560M
AUM Growth
+$560M
(+6.6%)
Cap. Flow
+$13.8M
Cap. Flow
% of AUM
2.47%
Top 10 Holdings %
Top 10 Hldgs %
68.23%
Holding
31
New
4
Increased
5
Reduced
7
Closed
5
Top Buys
| 1 |
UnitedHealth
UNH
|
$44.3M |
| 2 |
Insmed
INSM
|
$34.4M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$19.1M |
| 4 |
Exact Sciences
EXAS
|
$17.9M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$9.24M |
Top Sells
| 1 |
Danaher
DHR
|
$28.4M |
| 2 |
Transmedics
TMDX
|
$22M |
| 3 |
Natera
NTRA
|
$17.2M |
| 4 |
Sarepta Therapeutics
SRPT
|
$13.4M |
| 5 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
$12.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
CRISPR Therapeutics
CRSP
$4.71B
| – | – |
0
| – | – |
|
|
27
Danaher
DHR
$147B
| – | – |
-113,685
| Closed | -$28.4M |
|
28
Pacific Biosciences
PACB
$393M
| – | – |
-2,167,021
| Closed | -$8.13M |
|
|
29
Sarepta Therapeutics
SRPT
$1.78B
| – | – |
-103,256
| Closed | -$13.4M |
|
30
10x Genomics
TXG
$1.74B
| – | – |
-135,059
| Closed | -$5.07M |
|
|
FUSN
31
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| – | – |
-579,769
| Closed | -$12.4M |
|